Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living with HIV to Full Viral Suppression

Co-Investigator: Thomas Blue, Ph.D., Friends Research Institute
Co-Investigator: Ali Jalali, Ph.D., Weill Cornell Medical College
Co-Investigator: Raphael J. Landovitz, MD, MSc, University of California, Los Angeles
Funded By: National Institute on Drug Abuse
Grant #: R01DA056287
Total Project Period: 8/15/23 – 6/30/28